InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,385.60
(
0.33%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
74.24
(
0.68%
)
Bitcoin
63,713.82
(
0.61%
)
Post# of 253199
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120482
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 205439

Tuesday, 10/25/2016 4:53:35 PM

Tuesday, October 25, 2016 4:53:35 PM

Post# of 253199

...for all we know the risk of the drug at that point might be greater than the risk of stopping it...

If cost were no object, which decision would you make for yourself or a family member? (I know what my answer would be.)

Moreover, MRK's head of commercial operations, Adam Schechter, said on today's CC that the 24-month schedule in the FDA label will almost certainly not be an impediment to reimbursement for longer durations.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up